Venue: Huanglong Hotel, Hangzhou
Email: qicc@qicc.org, zjxg2010@126.com
CopyRight◎ QICC2024
Late-Breaking Clinical Trials (LBCT)
Submission Requirements
Contributors of accepted clinical studies will be invited to present at the QICC 2024 Congress in the Newly Revealed Clinical Trials Forum. By submitting a clinical study to the Congress, the contributor confirms that the study is nearing completion and will be presented at the QICC Congress upon acceptance, regardless of whether the results are positive or negative.
Deadline: 30 September 2024
Submission consultation: Shanshan Liu, 19560480875
Submission technical support: Mr. Feng, 18610065085
Email: sub@qiccmd.com